Genalyte Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genalyte Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10458
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genalyte Inc (Genalyte) is a lab testing service provider. The company’s services include data analysis, phlebotomist for blood draw, integration with existing emr, phlebotomist for blood draw, applications for test order and results review and clinical lab scientist. It provides instruments for detecting anti drug antibodies, autoimmune disease monitoring, testing for infectious agents and screening of cancer biomarkers. Genalyte also offers diagnostic services for running tests on urinalysis, immunology, pathogen screening, chemistry, esr and hematology. The company’s biosensors can be printed on a silicon chip making multi analyse panels of tests possible. Genalyte is headquartered in San Diego, California, the US.

Genalyte Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genalyte Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genalyte Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genalyte Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genalyte Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genalyte Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genalyte Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Genalyte Raises USD36 Million in Series D Financing 10
Genalyte Raises USD44 Million in Series C Financing Round 11
Genalyte Raises US$11.8 Million In Series B Financing 12
Partnerships 13
Genalyte Partners Scienion To Provide Sciflexarrayer Dispensers For Maverick Detection Platform 13
Genalyte Inc – Key Competitors 14
Genalyte Inc – Key Employees 15
Genalyte Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Dec 14, 2017: Genalyte hires Facebook and Google exec Kevin Lo as company president 17
Legal and Regulatory 18
Jan 24, 2018: Genalyte Receives ISO 13485 Medical Device Manufacturing Certification 18
Product News 19
Dec 13, 2017: Genalyte to Unveil & Exhibit its Diagnostic Cloud Lab During the 36th Annual J.P. Morgan Healthcare Conference 19
Other Significant Developments 20
Jan 03, 2018: Genalyte to Offer Patient Testing & Demonstration of its Diagnostic Cloud Lab in San Francisco January 7-11 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Genalyte Inc, Medical Equipment, Key Facts 2
Genalyte Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genalyte Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genalyte Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genalyte Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genalyte Inc, Deals By Market, 2012 to YTD 2018 8
Genalyte Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genalyte Raises USD36 Million in Series D Financing 10
Genalyte Raises USD44 Million in Series C Financing Round 11
Genalyte Raises US$11.8 Million In Series B Financing 12
Genalyte Partners Scienion To Provide Sciflexarrayer Dispensers For Maverick Detection Platform 13
Genalyte Inc, Key Competitors 14
Genalyte Inc, Key Employees 15

List of Figures
Genalyte Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genalyte Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genalyte Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genalyte Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genalyte Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genalyte Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genalyte Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genalyte Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genalyte Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WABCO Holdings Inc.:企業の戦略・SWOT・財務情報
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nabors Industries Ltd.:戦略・SWOT・企業財務分析
    Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • OmniComm Systems Inc (OMCM)-医療機器分野:企業M&A・提携分析
    Summary OmniComm Systems Inc (OmniComm) is a web-based electronic data capture and eClinical software and services providing company. It provides web-based applications to pharmaceutical, biotech and medical device companies. The company’s solutions allow clinical trial sponsors and investigative si …
  • Sutro Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADC’s), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways. Its pipeline …
  • Fluor Corporation (FLR):企業の財務・戦略的SWOT分析
    Fluor Corporation (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • RXi Pharmaceuticals Corp (RXII):製薬・医療:M&Aディール及び事業提携情報
    Summary RXi Pharmaceuticals Corp (RXi) is a biotechnology company that discovers, develops and commercializes immuno-oncology therapeutics to treat cancer. The company’s technology sd-rxRNA includes RXI-109 and IncRNA. Its lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of …
  • Yamaha Motor Co Ltd (7272):企業の財務・戦略的SWOT分析
    Yamaha Motor Co Ltd (7272) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • AGCO Corporation (AGCO):企業の財務・戦略的SWOT分析
    AGCO Corporation (AGCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Severn Trent Plc:企業の戦略・SWOT・財務分析
    Severn Trent Plc - Strategy, SWOT and Corporate Finance Report Summary Severn Trent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Consolidated Edison Company of New York Inc:電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New Y …
  • Accuray Inc (ARAY):医療機器:M&Aディール及び事業提携情報
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Voith GmbH & Co KGaA:企業の戦略的SWOT分析
    Voith GmbH & Co KGaA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Spectrum Brands Holdings, Inc.:企業の戦略・SWOT・財務分析
    Spectrum Brands Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spectrum Brands Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Singulex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Wal-Mart Stores Inc:戦略・SWOT・企業財務分析
    Wal-Mart Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Wal-Mart Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • RPC Group PLC:企業の戦略・SWOT・財務分析
    RPC Group PLC - Strategy, SWOT and Corporate Finance Report Summary RPC Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Energen Corporation:企業の戦略・SWOT・財務情報
    Energen Corporation - Strategy, SWOT and Corporate Finance Report Summary Energen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆